SULLIVAN LOUIS W bought UTHR
December 22, 2025 · Form 4 insider transaction
SULLIVAN LOUIS W bought 2,720 shares of United Therapeutics Corporation at $229.81 per share, a transaction worth $625.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,720
Price
$229.81
Total value
$625.1K
InsiderSULLIVAN LOUIS W
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 22, 2025
Filing dateDecember 23, 2025
Shares owned after5,950
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power.